Systemic inflammation in heart failure--the whys and wherefores.
about
Novel Molecular Approaches in Heart Failure: Seven Trans-Membrane Receptors Signaling in the Heart and Circulating Blood LeukocytesRespiratory and limb muscle dysfunction in pulmonary arterial hypertension: a role for exercise training?Erectile dysfunction in heart failure patients: a critical reappraisalLeft Ventricular T-Cell Recruitment Contributes to the Pathogenesis of Heart Failure.Effects of fish oil supplementation on inflammatory markers in chronic heart failure: a meta-analysis of randomized controlled trials.The effect of rosuvastatin on inflammation, matrix turnover and left ventricular remodeling in dilated cardiomyopathy: a randomized, controlled trial.Toll-Like Receptor 9 Promotes Survival in SERCA2a KO Heart Failure Mice.Expression of pericardial fluid T-cells and related inflammatory cytokines in patients with chronic heart failure.Impaired thymic export and apoptosis contribute to regulatory T-cell defects in patients with chronic heart failureCardiac remodeling in obesity.Low-level laser therapy improves the inflammatory profile of rats with heart failure.Comparison of whole blood and peripheral blood mononuclear cell gene expression for evaluation of the perioperative inflammatory response in patients with advanced heart failure.Increased levels of plasma soluble Sema4D in patients with heart failure.Temporal and gefitinib-sensitive regulation of cardiac cytokine expression via chronic β-adrenergic receptor stimulation.White blood cell count, C-reactive protein, and incident heart failure in the Atherosclerosis Risk in Communities (ARIC) StudyUp-regulated TLR4 in cardiomyocytes exacerbates heart failure after long-term myocardial infarction.Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence.Serum Soluble Urokinase-Type Plasminogen Activator Receptor Is Associated with Low Left Ventricular Ejection Fraction and Elevated Plasma Brain-Type Natriuretic Peptide LevelNeutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio are Predictors of Heart Failure.Changes in the monocytic subsets CD14(dim)CD16(+) and CD14(++)CD16(-) in chronic systolic heart failure patients.Role of xanthine oxidoreductase in cardiac nitroso-redox imbalanceInhibition of brain proinflammatory cytokine synthesis reduces hypothalamic excitation in rats with ischemia-induced heart failure.CARD9 knockout ameliorates myocardial dysfunction associated with high fat diet-induced obesity.Lipoprotein-associated phospholipase A(2) and risk of congestive heart failure in older adults: the Cardiovascular Health Study.Metabolic syndrome, inflammation, and incident heart failure in the elderly: the cardiovascular health study.Morphological and molecular changes of the myocardium after left ventricular mechanical supportThe G-308A polymorphism of the TNF-alpha gene does not predict changes in cardiac function in response to medical therapy for idiopathic dilated cardiomyopathy.T cell costimulation blockade blunts pressure overload-induced heart failure.Cardiac asthma: new insights into an old disease.Mechanisms for cachexia in heart failure.Mendelian forms of structural cardiovascular disease.The mononuclear phagocyte system in homeostasis and disease: a role for heme oxygenase-1.Interleukin-6 signaling, soluble glycoprotein 130, and inflammation in heart failure.Targeting interleukin-1 in heart failure and inflammatory heart disease.A Central Role for Monocyte-Platelet Interactions in Heart Failure.Cardiac telomere length in heart development, function, and disease.IL-18 stimulates B-type natriuretic peptide synthesis by cardiomyocytes in vitro and its plasma levels correlate with B-type natriuretic peptide in non-overloaded acute heart failure patients.Striated muscle activator of Rho signaling is required for myotube survival but does not influence basal protein synthesis or degradation.Attenuation of monocyte chemotaxis--a novel anti-inflammatory mechanism of action for the cardio-protective hormone B-type natriuretic peptide.Chronic exercise leads to antiaggregant, antioxidant and anti-inflammatory effects in heart failure patients.
P2860
Q26776138-5EA09BC6-7A50-41EC-9E2A-A8FDCCBEE9E2Q26781677-2AF12E10-E970-430F-B398-B132DD050756Q26853624-46E33607-7009-4BA4-AF05-871202D32B30Q27340146-3EB44CC7-28B0-404D-8787-F815B7BC1C0BQ31096498-ED266AF1-87FB-4F83-93ED-FE039D8DE3C7Q31152172-FA613E67-29D5-49CB-9040-64A17EB2E0E6Q33604761-F5F51DC8-359A-4291-95E6-658D7817B9F2Q33723800-3FDD69DC-56CB-4A44-AE1D-42156B84618FQ34026055-7C96082A-F6BB-4842-AFF9-154CF94E0FD3Q34043589-AAB198C7-4F4C-406D-A21F-1D3F36DBB60CQ34398672-402F62CB-62A4-4F49-B266-17CB70947780Q34724232-AD2AAB73-11EE-499A-8FAC-24ADCB0F0CFFQ34760436-F2672DB3-490A-44E1-A80E-96F7994428C2Q35086445-B029EA15-57E0-4D26-85EE-72CB808F6777Q35194633-0A59150D-A3E5-4ABB-860E-FDFAECDCDC29Q35750924-46E83AD6-3FC2-48BE-8A6B-EA4B7DE27D4EQ35784024-B87B7D11-E506-43BB-BD58-6E0B1F9DC4D9Q36263895-431AE1ED-DC9C-406C-A815-33F790F497DFQ36410460-E4161B49-CFFB-445A-89D7-DF61BF5F108AQ36446773-EAA3DA7F-46E6-439E-B736-3AC49AA1B642Q36557850-5B8C13D6-C645-4121-A2D2-D7732F9E2127Q36807972-BAD91479-65C4-4939-BD9D-2901A72C7E3CQ36997173-F8A800DA-AFDB-4DF3-BDD4-1D94A7B5E71FQ37374474-62DC4C7D-685F-4747-86F0-FFE395D7FFFAQ37388985-AC066C26-0E8D-4D8C-B3C1-B0FC2AA3C702Q37638247-9F9945C2-00B4-4BBD-B33D-60FFE8F4FA9AQ37687213-95674AD5-3B19-4184-A297-41AE5E3DDFE0Q37690286-A78695BD-21C9-4DEC-8403-965D930EE506Q38066986-F32803DC-87A3-4418-9DA3-11A3F1C8AF5EQ38127358-D24D4537-3C1A-4798-858C-F3BDAFA5AEF8Q38138883-110F7CF6-03C2-4929-9243-2739F8CA88C7Q38154630-80579B57-56C8-4C77-AE6F-A2C811982DEDQ38183314-42B10014-F86C-45CC-B90F-25D4E299B79BQ38260179-34E0E4B5-A470-4D98-A085-6986216E645FQ38620927-8E22B0D7-5408-49DA-8277-7CBF50FED58DQ38678302-49388ED6-A796-40A4-9D57-BA6A0792A45BQ39019354-B19BA55C-E985-4D69-BE06-7E255AE642B7Q39145978-1490E37C-324D-4B08-B401-D00D02B952F4Q39159036-D53119C1-32E4-4329-A11A-689D5E4C303FQ39414645-CB5D9AF1-F539-4D20-84A3-90C61F6B0A45
P2860
Systemic inflammation in heart failure--the whys and wherefores.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Systemic inflammation in heart failure--the whys and wherefores.
@ast
Systemic inflammation in heart failure--the whys and wherefores.
@en
type
label
Systemic inflammation in heart failure--the whys and wherefores.
@ast
Systemic inflammation in heart failure--the whys and wherefores.
@en
prefLabel
Systemic inflammation in heart failure--the whys and wherefores.
@ast
Systemic inflammation in heart failure--the whys and wherefores.
@en
P2860
P50
P1476
Systemic inflammation in heart failure--the whys and wherefores.
@en
P2093
P2860
P2888
P356
10.1007/S10741-006-9196-2
P577
2006-03-01T00:00:00Z